SCHEMBL5495692

SCHEMBL5495692

O=C(Cl)C(=O)Cl.O=C(Cl)c1ccc(F)c(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
MAOB P27338 4/20 0.40
IDO1 P14902 4/20 0.38
PGR P06401 1/20 0.38
TDO2 P48775 2/20 0.38
SLC9A1 P19634 1/20 0.37
MAOA P21397 3/20 0.36
CTSL P07711 1/20 0.35
ALDH1A1 P00352 2/20 0.35
ALOX15 P16050 1/20 0.35
VCP P55072 1/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146573 0.96 NPC1 (0.46) NPC1RAB9ACES2CES1MAOB
SCHEMBL321581 0.80 CES2 (0.43) NPC1RAB9ACES2CES1MAOB
SCHEMBL30817696 0.79 ALDH1A1 (0.52) NPC1RAB9ACES2CES1MAOB
SCHEMBL104151 0.78 TTR (0.50) NPC1RAB9ACES2CES1MAOB
SCHEMBL31302316 0.78 TTR (0.50) NPC1RAB9ACES2CES1MAOB
SCHEMBL9215548 0.78 NPC1 (0.47) NPC1RAB9ACES2CES1MAOB
SCHEMBL10555693 0.78 CES2 (0.45) NPC1RAB9ACES2CES1MAOB
SCHEMBL7683262 0.77 MAPT (0.40) NPC1CES2CES1ALDH1A1CA1
SCHEMBL29470947 0.77 CES2 (0.67) NPC1RAB9ACES2CES1ALDH1A1
SCHEMBL192962 0.77 CES2 (0.67) NPC1RAB9ACES2CES1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC. (US) 2007-09-26 EP disclosed
WO-2006039718-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2006-04-13 WO disclosed